Fibroblast lipid metabolism through ACSL4 regulates epithelial sensitivity to ferroptosis in IBD
- PMID: 40571769
- PMCID: PMC12444769
- DOI: 10.1038/s42255-025-01313-x
Fibroblast lipid metabolism through ACSL4 regulates epithelial sensitivity to ferroptosis in IBD
Abstract
Increased reactive oxygen species (ROS) levels are a hallmark of inflammatory bowel disease (IBD) and constitute a major mechanism of epithelial cell death. Approaches to broadly inhibit ROS have had limited efficacy in treating IBD. Here we show that lipid peroxidation contributes to the pathophysiology of IBD by promoting ferroptosis, an iron-dependent form of programmed cell death. Mechanistically, we provide evidence of heterocellular crosstalk between intestinal fibroblasts and epithelial cells. In IBD tissues and mouse models of chronic colitis, acyl-CoA synthetase long-chain family 4 (ACSL4) is overexpressed in fibroblasts. ACSL4 in fibroblasts reprograms lipid metabolism and mediates intestinal epithelial cell sensitivity to ferroptosis. In mouse models, overexpressing ACSL4 in fibroblasts results in increased intestinal epithelial ferroptosis and worsened colitis, while pharmacological inhibition or deletion of fibroblast ACSL4 ameliorates colitis. Our work provides a targeted approach to therapeutic antioxidant treatments for IBD.
© 2025. The Author(s), under exclusive licence to Springer Nature Limited.
Conflict of interest statement
Competing interests: The authors declare no competing interests.
References
MeSH terms
Substances
Grants and funding
- R01 CA148828/CA/NCI NIH HHS/United States
- R35 ES035027/ES/NIEHS NIH HHS/United States
- R01 DK095201/DK/NIDDK NIH HHS/United States
- R01CA148828/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
- RC2DK140862/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
- P30ES017885/U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (NIEHS)
- R01 ES028802/ES/NIEHS NIH HHS/United States
- P30 DK046200/DK/NIDDK NIH HHS/United States
- R21CA273646/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
- R37 CA262209/CA/NCI NIH HHS/United States
- S10 OD021750/OD/NIH HHS/United States
- F30DK131851/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
- R01DK095201/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
- S10OD021750/U.S. Department of Health & Human Services | NIH | NIH Office of the Director (OD)
- R01DK137806/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
- P30 CA046592/CA/NCI NIH HHS/United States
- R01 DK137806/DK/NIDDK NIH HHS/United States
- R01 CA245546/CA/NCI NIH HHS/United States
- R21 CA273646/CA/NCI NIH HHS/United States
- F30 DK131851/DK/NIDDK NIH HHS/United States
- R35ES035027/U.S. Department of Health & Human Services | NIH | National Institute of Environmental Health Sciences (NIEHS)
- R01CA245546/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
- RC2 DK140862/DK/NIDDK NIH HHS/United States
- R37CA262209/U.S. Department of Health & Human Services | NIH | National Cancer Institute (NCI)
- P30 ES017885/ES/NIEHS NIH HHS/United States
- P30DK046200/U.S. Department of Health & Human Services | NIH | National Institute of Diabetes and Digestive and Kidney Diseases (National Institute of Diabetes & Digestive & Kidney Diseases)
- R01 DK059888/DK/NIDDK NIH HHS/United States
LinkOut - more resources
Full Text Sources
